Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

636 ARTÍCULOS , VIENDO DEL 226 AL 240

Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment

Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP.

Mov Disord. 2018 Apr;33(4):503-510. doi: 10.1002/mds.27323. Epub 2018 Feb 28.

Parkinson's disease: A Quick Update

D'Abreu A.

R I Med J (2013). 2018 Mar 1;101(2):34-36.

Parkinson's disease: A review

Radhakrishnan DM, Goyal V.

Neurol India. 2018 Mar-Apr;66(Supplement):S26-S35. doi: 10.4103/0028-3886.226451.

Tremor syndromes: A review

Kamble N, Pal PK.

Neurol India. 2018 Mar-Apr;66(Supplement):S36-S47. doi: 10.4103/0028-3886.226440.

Neuroimaging in Parkinsonian Disorders

Tripathi M, Kumar A, Bal C.

Neurol India. 2018 Mar-Apr;66(Supplement):S68-S78. doi: 10.4103/0028-3886.226460.

Optimizing Parkinson's disease diagnosis: the role of a dual nuclear imaging algorithm

Langston JW, Wiley JC, Tagliati M.

NPJ Parkinsons Dis. 2018 Feb 23;4:5. doi: 10.1038/s41531-018-0041-9. eCollection 2018.

Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies

Palma JA, Kaufmann H.

Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344.

Autonomic dysfunction in genetic forms of synucleinopathies

Chelban V, Vichayanrat E, Schottlaende L, Iodice V, Houlden H.

Mov Disord. 2018 Mar;33(3):359-371. doi: 10.1002/mds.27343.

Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease

Christine CW, Auinger P, Joslin A, Yelpaala Y, Green R; Parkinson Study Group-DATATOP Investigators.

Mov Disord. 2018 May;33(5):762-770. doi: 10.1002/mds.27301. Epub 2018 Mar 6.

Voluntary inhibitory motor control over involuntary tic movements

Ganos C, Rothwell J, Haggard P.

Mov Disord. 2018 Jul;33(6):937-946. doi: 10.1002/mds.27346. Epub 2018 Mar 6.

Intensive inpatient rehabilitation for persons with Parkinson's disease: last resort or pre-emptive strike?

Radder DLM, Nonnekes J, Bloem BR.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):795-796. doi: 10.1136/jnnp-2017-317812. Epub 2018 Mar 13.

Initial cognitive changes in Parkinson's disease

Weintraub D, Tröster AI, Marras C, Stebbins G.

Mov Disord. 2018 Apr;33(4):511-519. doi: 10.1002/mds.27330. Epub 2018 Mar 15.

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future

Auffret M, Drapier S, Vérin M.

Drugs R D. 2018 Jun;18(2):91-107. doi: 10.1007/s40268-018-0230-3.

Functional neurological disorders in Parkinson disease

Wissel BD, Dwivedi AK, Merola A, Chin D, Jacob C, Duker AP, Vaughan JE, Lovera L, LaFaver K, Levy A, Lang AE, Morgante F, Nirenberg MJ, Stephen C, Sharma N, Romagnolo A, Lopiano L, Balint B, Yu XX, Bhatia KP, Espay AJ.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):566-571. doi: 10.1136/jnnp-2017-317378. Epub 2018 Mar 16.

Current perspective of mitochondrial biology in Parkinson's disease

Ammal Kaidery N, Thomas B.

Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias